• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

POLL: Are you concerned about the recent black box warning given to JAK inhibitors?

Poll

Click here to answer our weekly poll.

Are you concerned about the recent black box warning given to upcoming JAK inhibitors baricitinib and upadacitinib?

Yes
No
Only a little
Related Content
POLL: Would You Consider Utilizing Virtual Reality in Your Practice or to Further Your Education?

POLL: Would You Consider Utilizing Virtual Reality in Your Practice or to Further Your Education?

Article
What Conferences Are You Planning to Attend in Quarter 2 of 2024?

What Conferences Are You Planning to Attend in Quarter 2 of 2024?

Article
POLL: What Topic Do You Most Want Us to Cover at the American Academy of Dermatology Annual Meeting?

POLL: What Topic Do You Most Want Us to Cover at the American Academy of Dermatology Annual Meeting?

Article
POLL: Are You Attending the American Academy of Dermatology Annual Meeting?

POLL: Are You Attending the American Academy of Dermatology Annual Meeting?

Article
POLL: Which of These Rare Dermatologic Diseases Have You Encountered in Your Practice?

POLL: Which of These Rare Dermatologic Diseases Have You Encountered in Your Practice?

Article
Surveying Our Readers: What Are Your Thoughts on the New AAD Acne Guidelines?

Surveying Our Readers: What Are Your Thoughts on the New AAD Acne Guidelines?

Article
© 2024 MJH Life Sciences

All rights reserved.